IRCT20231120060123N1招募中3 期
Investigating the effects of Silymarin in the Prevention of hyperbilirubinemia: a randomized, double-blind, placebo-controlled, clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 days 至 10 days（—）
- 性别
- All
入选标准
- •Full-term newborns who are negative for the Coombs test at birth.
- •Healthy full-term newborns who do not require phototherapy.
- •Newborns whose bilirubin levels are not in the range requiring blood exchange.
- •Newborns with no history of the mother taking any kind of medication during pregnancy.
排除标准
- •Newborns with RH incompatibility who are positive for the Coombs test.
- •Newborns with an increase in bilirubin to the level requiring blood exchange.
- •Newborns requiring phototherapy on the first day of birth.
- •Deterioration in the newborn's condition during hospitalizationwith dehydration, sepsis, pneumonia, anemia, severe weight loss, hypoglycemia, renal failure, or heart failure.
- •Newborns with a history of the mother taking any kind of medication during pregnancy or mothers who have received phenobarbital.
- •Newborns who experience severe drug reactions following the use of silymarin.
- •Parents' refusal to continue treatment.
研究者
相似试验
招募中
3 期
Investigating the effects of Silymarin in the treatment of neonatal jaundiceIRCT20211122053144N1Mashhad University of Medical Sciences60
尚未招募
3 期
Evaluating the effectiveness of silymarin in preventing vancomycin nephrotoxicityVancomycin-induced nephrotoxicity in hospitalized patients.Drug- and heavy-metal-induced tubulo-interstitial and tubular conditionsIRCT20161010030246N6Shiraz University of Medical Sciences80
招募中
3 期
Evaluating the effectiveness of Silymarin on the prevention of gentamicin nephrotoxicityGentamicin-induced renal toxicity in hospitalized patients.Other bacterial diseasesA30-A49IRCT20161010030246N3Shiraz University of Medical Sciences60
尚未招募
3 期
Effect of silymarin in the treatment of patients with depressioIRCT20160804029191N4Mashhad University of Medical Sciences80
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140